| Amycolatopsis| Amycolatopsis Lechevalier et al. 1986 emend. Lee 2009| Amycolatopsis Lechevalier et al. 1986 emend. Nouioui et al. 2018| Amycolatopsis Lechevalier et al. 1986 emend. Tang et al. 2010
Soft Tissue Infections: Amycolatopsis species have been sporadically implicated in soft tissue infections, including cellulitis, abscesses, and wound infections. These infections may occur following trauma or surgery, especially in individuals with compromised immune systems.
Respiratory Infections: In rare cases, Amycolatopsis species have been isolated from respiratory specimens in individuals with respiratory symptoms, such as cough, fever, and shortness of breath. These infections may occur in individuals with chronic lung diseases or immunosuppression.
Catheter-Related Infections: Like other opportunistic pathogens, Amycolatopsis species have been reported as causes of catheter-related infections, particularly in individuals with indwelling urinary or central venous catheters. These infections can lead to bacteremia and septicemia if not promptly treated.
Prosthetic Joint Infections: Amycolatopsis species have been implicated in prosthetic joint infections, which can occur following joint replacement surgery or other orthopedic procedures. These infections may result in joint pain, swelling, and limited mobility.
Other Sources for more information:
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.2598833441734314 | 0.633242666721344 | Thauera | Parent Taxa |
R2 | Slope | Tax Name | Parent Chart |
---|---|---|---|
0.25428342819213867 | 0.5024759769439697 | Methylobacterium | Parent Taxa |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]